Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.92B | 6.25B | 7.12B | 6.31B | |
| Total Receivables | 2.35B | 2.83B | 2.20B | 1.97B | |
| Inventory | 1.95B | 1.77B | 1.63B | 1.56B | |
| Prepaid Expenses | -- | 158.53M | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 259.21M | 103.62M | 273.36M | 292.35M | |
| Total Current Assets | 10.48B | 11.10B | 11.23B | 10.13B | |
|
|
|||||
| Total Current Assets | 10.48B | 11.10B | 11.23B | 10.13B | |
| Net Property, Plant & Equipment | 3.10B | 3.06B | 3.27B | 3.10B | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 364.68M | 347.85M | 230.75M | 115.66M | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 521.01M | 563.21M | 499.18M | 949.29M | |
| Total Assets | 15.07B | 15.74B | 15.79B | 14.29B | |
|
|
|||||
| Total Accounts Payable | 988.65M | 811.59M | 543.52M | 471.37M | |
| Total Accrued Expenses | -- | 341.81M | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | 49.58M | -- | -- | |
| Total Finance Division Other Current Liabilities | 1.42B | 1.42B | 1.32B | 920.50M | |
| Total Other Current Liabilities | 1.42B | 1.42B | 1.32B | 920.50M | |
| Total Current Liabilities | 2.41B | 2.62B | 1.86B | 1.39B | |
|
|
|||||
| Total Current Liabilities | 2.41B | 2.62B | 1.86B | 1.39B | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | 114.40M | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 184.95M | 88.33M | 172.89M | 159.14M | |
| Total Liabilities | 2.60B | 2.82B | 2.03B | 1.55B | |
|
|
|||||
| Common Stock & APIC | 861.92M | 916.63M | 994.43M | 957.23M | |
| Retained Earnings | 11.57B | 12.05B | 12.81B | 11.69B | |
| Treasury Stock & Other | 47.24M | -51.20M | -40.64M | 90.26M | |
| Total Common Equity | 12.47B | 12.92B | 13.76B | 12.74B | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 12.47B | 12.92B | 13.76B | 12.74B | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 12.47B | 12.92B | 13.76B | 12.74B | |
|
|
|||||